Cancer is a complex disease that evades the immune system through various mechanisms. The rapid proliferation of cells and their ability to resist therapy make cancer extremely aggressive. Solid ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

New research is challenging one of medicine’s oldest assumptions: that cancer must be attacked to be cured. By treating ...

GRAND RAPIDS, Mich. — BAMF Health, a cancer treatment center in Grand Rapids, has launched a study to better understand a certain type of breast cancer. The non-invasive study seeks to find whether or ...

New research reveals that intermittent fasting can significantly enhance the effectiveness of oestrogen-blocking breast ...

Breast cancer remains one of the predominant causes of cancer-related morbidity worldwide. In recent years, research has increasingly focused on the role of immune markers in predicting patient ...

Predictive and prognostic markers are at the forefront of personalised cancer care, offering clinicians the ability to both anticipate a patient’s response to specific therapies and gauge the likely ...

Researchers at the University of Texas at El Paso have developed a device they say can detect cancer markers in the blood with greater responsiveness than current diagnostic methods. The University of ...

In a recent study published in eBioMedicine, researchers evaluate the causal relevance of circulating inflammatory markers in cancer risk using a two-stage Mendelian randomization (MR) design and a ...

When we feel unwell and don't know why, a blood test is often the first step in figuring out what's wrong. But, despite what some may think, these tests don't actually identify every possible major ...